By Kristin Beerman | email
Edited by Jon Bush | email
LUBBOCK, TX (KCBD) – The FDA is considering expanding the use of two popular types of drug as preventive medicine. Right now, Adovart is prescribed to reduce prostate inflammation, but there is evidence that it may also reduce the risk of prostate cancer by as much as 24%.
So, its makers are asking the FDA for the okay to sell it for that reason as well. Also, the makers of cholesterol reducing statins, such as Crestor, are asking the FDA to allow Crestor to be sold to millions of people with normal cholesterol levels, now that studies have shown it can reduce the rate of creactive protein, which is another risk factor later in life.
"A quarter of a million heart attacks, strokes, bypass surgeries, angioplasties, and cardiovascular deaths could be avoided if the strategy of that was tested here was actually used over a five year period," said Dr. Paul Ridker, with Brigham and Women's Hospital.
On the flip side, some doctors are advising against the expanded use of these drugs because of possible side effects.
©2010 KCBD NewsChannel 11. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.